Product Information
LEVETIRACETAM 250 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.0584 per EA under NDC 67877076805. Its NADAC has been published 200 times since Oct 26, 2022.
FDA first approved this application on May 27, 2022. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
250 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877076805
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA216375FDA Approved
5/27/2022
TE Code
AB
On Market Since
5/28/2022
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 250 MG TABLET has been published 200 times since Oct 26, 2022, and over the history we have for it it has declined 17.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0584 per EA |
|---|---|
| All-time high | $0.0740 (Dec 13, 2023) |
| All-time low | $0.0454 (Nov 20, 2024) |
| 52-week high | $0.0629 |
| 52-week low | $0.0562 |
| Median price | $0.0626 |
| Average price | $0.0620 |
| Largest weekly change | +30.7% (Aug 21, 2024) |
| Weeks tracked | 200 |
| Tracking since | Oct 26, 2022 |
Generic Alternatives
The matcher finds 17 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 15% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 250 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 250 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.0584 per EA (NDC 67877076805), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 250 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 250 MG TABLET has declined 17.7%. It has been tracked across 200 weekly CMS publications since Oct 26, 2022.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 250 MG TABLET?
Since Oct 26, 2022, the NADAC for LEVETIRACETAM 250 MG TABLET has ranged from a low of $0.0454 (Nov 20, 2024) to a high of $0.0740 (Dec 13, 2023), with a median of $0.0626 per EA.
Are there cheaper alternatives to LEVETIRACETAM 250 MG TABLET?
Yes. 17 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 250 MG TABLET, is $0.0494 per EA — about 15% below LEVETIRACETAM 250 MG TABLET.
Who manufactures LEVETIRACETAM 250 MG TABLET?
LEVETIRACETAM 250 MG TABLET (NDC 67877076805) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.